Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Gangrene Treatment Market size was over USD 1.78 billion in 2024 and is poised to exceed USD 4.09 billion by 2037, witnessing over 6.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of gangrene treatment is evaluated at USD 1.88 billion.
The growth of the gangrene treatment market can be attributed to factors such as the increasing prevalence of diabetes and its related complications, growing demand for sophisticated therapies and rising number of incidences of severe traumatic injuries. According to the World Health Organization (WHO), diabetes is a major cause of blindness, stroke and lower limb amputation. Along with these, growth in the total obese population worldwide is projected to offer ample opportunities to market growth in the coming years.
Gangrene Treatment Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Prevalence of Diabetes and Related Complications
- Increasing Demand for Sophisticated Therapies for Gangrene
Challenges
- High Cost of Treatment and Management of the Condition
Gangrene Treatment Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.60% |
|
Base Year Market Size (2024) |
USD 1.78 billion |
|
Forecast Year Market Size (2037) |
USD 4.09 billion |
|
Regional Scope |
|
Gangrene Treatment Segmentation
The market is segmented by condition type into dry, wet, internal, gas gangrene, and others out of which, the gas gangrene segment is anticipated to drive notable growth in the gangrene treatment market on account of rise in occurrence of arterial diseases, colon cancer and muscle injuries. Apart from this, it is a very common type of gangrene, which can also be credited to boost the demand for treatment drugs in the near future. Furthermore, on the basis of treatment type, the hyperbaric oxygen therapy is expected to gather the largest market share during the forecast period owing to the increasing incidences of diabetic foot ulcers, speedy healing process of the treatment and its effectiveness in killing bacteria.
Our in-depth analysis of the global market includes the following segments
|
By Condition Type |
|
|
By Treatment Type |
|
|
By Distribution Channel
|
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportGangrene Treatment Industry - Regional Synopsis
North America Market Statistics
On the basis of geographical analysis, the gangrene treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. North America industry is likely to dominate majority revenue share by 2037, on the back of strong presence of leading industry players, increasing healthcare budget and growing technological advancements in the healthcare sector.
Europe Market Analysis
Additionally, Europe is evaluated to be the second largest shareholder in the gangrene treatment market in the coming years ascribing to the growing investments in R&D activities in the region. However, the market in Asia Pacific is expected to grow with the highest CAGR during the forecast period, which can be credited to the growing number of cases of gangrene affecting mouth, nose and lips, and the increasing geriatric population in the region
Companies Dominating the Gangrene Treatment Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Antidote Therapeutics, Inc.
- Ixaka Ltd
- Pluristem Therapeutics Inc.
- LimFlow SA
- Viatris Inc.
- Hikma Pharmaceuticals PLC
- Allergan plc
- AKORN, INC.
- Atox Bio
In the News
Author Credits: Radhika Pawar
- Report ID: 3076
- Published Date: Dec 26, 2024
- Report Format: PDF, PPT
